European Atherosclerosis Society recommends screening for Lp(a)
from Heartwire via Medscape Medical News
Patients at high to moderate risk of cardiovascular disease should be screened for elevated levels of lipoprotein(a) (Lp[a]) and take niacin to bring their Lp(a) level under 50 mg/dL, according to a consensus statement from the European Atherosclerosis Society (EAS) . The EAS consensus panel's new scientific consensus statement on Lp(a) is not yet published, but the key points of the statement were announced during the final session of the EAS 2010 Congress by Dr Børge Nordestgaard (University of Copenhagen, Denmark), who led some of the key studies supporting the statement.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063